Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
16477 | 586 | 32.5 | 58% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
202 | 20434 | CLOPIDOGREL//PRASUGREL//ASPIRIN RESISTANCE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | RECEPTOR C K | Author keyword | 27 | 92% | 2% | 11 |
2 | PLATELET THROMBOXANE FORMATION | Author keyword | 2 | 67% | 0% | 2 |
3 | REFLECTION CONTRAST MICROSCOPY | Author keyword | 2 | 36% | 1% | 4 |
4 | BCL 2 AND CYCLIN D EXPRESSION | Author keyword | 1 | 100% | 0% | 2 |
5 | CLIN CHEM HAEMATOL G03 550 | Address | 1 | 50% | 0% | 2 |
6 | RECEPTOR C K INDUCTION | Author keyword | 1 | 100% | 0% | 2 |
7 | THROMBOSIS HAEMOSTASIS G03 647 | Address | 1 | 100% | 0% | 2 |
8 | DENSE GRANULE SECRETION | Author keyword | 1 | 40% | 0% | 2 |
9 | GLYCOPROTEINS IIB IIIA | Author keyword | 1 | 33% | 0% | 2 |
10 | AML PATIENTS | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IIA HYPERCHOLESTEROLEMIC SUBJECTS | 3 | 100% | 1% | 3 |
2 | C K | 3 | 60% | 1% | 3 |
3 | RECEPTOR C K | 3 | 60% | 1% | 3 |
4 | MALONDIALDEHYDE FORMATION | 2 | 50% | 1% | 3 |
5 | IIA HYPERCHOLESTEROLEMIA | 2 | 23% | 1% | 7 |
6 | IIB BETA 3 | 1 | 50% | 0% | 2 |
7 | THROMBOXANE A2 TXA2 | 1 | 50% | 0% | 2 |
8 | THROMBOXANE B2 | 1 | 13% | 2% | 9 |
9 | ADMINISTERED LIPID EMULSIONS | 1 | 50% | 0% | 1 |
10 | BLEEDING TIME WOUNDS | 1 | 50% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Low-density lipoprotein and its effect on human blood platelets | 2003 | 50 | 104 | 57% |
PLATELET REACTIVITY AND ARACHIDONIC-ACID METABOLISM IN TYPE-II HYPERLIPOPROTEINEMIA AND ITS MODIFICATION BY CHOLESTEROL-LOWERING AGENTS | 1990 | 45 | 47 | 64% |
High-density lipoproteins, platelets and the pathogenesis of atherosclerosis | 2010 | 44 | 99 | 24% |
BINDING CHARACTERISTICS OF HOMOLOGOUS PLASMA-LIPOPROTEINS TO HUMAN PLATELETS | 1992 | 17 | 13 | 92% |
PLATELET ACTIVATION BY PLASMA-LIPOPROTEINS | 1987 | 112 | 64 | 59% |
PLATELETS AND THE LIPOPROTEINS - NATIVE, MODIFIED AND PLATELET MODIFIED LIPOPROTEINS | 1994 | 35 | 151 | 56% |
Modified low-density lipoproteins and high-density lipoproteins | 2006 | 4 | 174 | 42% |
LIPOPROTEIN RECEPTOR-C-K ACTIVATION RESPONSE COUPLING IN HUMAN PLATELETS | 1995 | 2 | 11 | 73% |
THE EFFECTS OF PLASMA-LIPOPROTEINS ON PLATELET RESPONSIVENESS AND ON PLATELET AND VASCULAR PROSTANOID SYNTHESIS | 1989 | 27 | 40 | 55% |
Cellular phospholipid uptake: Flexible paths to coregulate the functions of intracellular lipids | 2010 | 16 | 52 | 15% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLIN CHEM HAEMATOL G03 550 | 1 | 50% | 0.3% | 2 |
2 | THROMBOSIS HAEMOSTASIS G03 647 | 1 | 100% | 0.3% | 2 |
3 | CARDIOVASC METAB DIABETOL NUTR CARMEN | 1 | 50% | 0.2% | 1 |
4 | MED R P ORT MED SCI | 1 | 50% | 0.2% | 1 |
5 | MED RAYNE CLIN PHARMACOL | 1 | 50% | 0.2% | 1 |
6 | MIDDLESEX HOSP MEDSIR JULES THORN | 1 | 50% | 0.2% | 1 |
7 | THROMBOSIS 013 014 | 1 | 50% | 0.2% | 1 |
8 | UNITAT RECERCA LIPIDS ANTERIOSCLEROSI | 1 | 50% | 0.2% | 1 |
9 | KAMPO S MIYAKOJIMA KU | 0 | 25% | 0.2% | 1 |
10 | LEIBNITZ ARTERIOSKLEROSEFOR | 0 | 25% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000165132 | T CADHERIN//H CADHERIN//CDH13 |
2 | 0.0000096430 | DIABETOL DDG//JOHN COOK RENAL UNIT//PLATELET HYPERSENSITIVITY |
3 | 0.0000087796 | TRAPIDIL//CAS 15421 84 8//SEKT KLIN PHARMAKOL |
4 | 0.0000083665 | PROSTACYCLIN STIMULATING FACTOR//CANINE PLATELET//CELLULAR METABOLITES |
5 | 0.0000082325 | OXIDIZED LDL//LOW DENSITY LIPOPROTEIN//LIPOPROTEIN OXIDATION |
6 | 0.0000075189 | HUMAN PLATELET//PLATELETS HUMAN//ATPASE CA2 MG2 |
7 | 0.0000069186 | TRANSGENES CARDIOVASC CONTROL//SILICONE COLLAR//WHHL RABBIT |
8 | 0.0000067076 | AGE RELATED DECREASE IN PGI2 PRODUCTION//EN FACE TECHNIQUE//15 ISOPROSTANE F 2T |
9 | 0.0000065571 | JOINT EFFUSIONS//JUMPING HORSE//MED BLOOD TRANSFUS UNIT |
10 | 0.0000064924 | MEAN PLATELET VOLUME//PLATELET DISTRIBUTION WIDTH//PLATELET INDICES |